Correction to: Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.

MLA

Sakuma, Ichiro, et al. “Correction to: Clinical Risk Factors of Stroke and Major Bleeding in Patients with Non-Valvular Atrial Fibrillation under Rivaroxaban: The EXPAND Study Sub-Analysis.” Heart & Vessels, vol. 34, no. 11, Nov. 2019, pp. 1852–57. EBSCOhost, https://doi.org/10.1007/s00380-019-01479-x.

APA

Sakuma, I., Uchiyama, S., Atarashi, H., Inoue, H., Kitazono, T., Yamashita, T., Shimizu, W., Ikeda, T., Kamouchi, M., Kaikita, K., Fukuda, K., Origasa, H., & Shimokawa, H. (2019). Correction to: Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis. Heart & Vessels, 34(11), 1852–1857. https://doi.org/10.1007/s00380-019-01479-x

Chicago

Sakuma, Ichiro, Shinichiro Uchiyama, Hirotsugu Atarashi, Hiroshi Inoue, Takanari Kitazono, Takeshi Yamashita, Wataru Shimizu, et al. 2019. “Correction to: Clinical Risk Factors of Stroke and Major Bleeding in Patients with Non-Valvular Atrial Fibrillation under Rivaroxaban: The EXPAND Study Sub-Analysis.” Heart & Vessels 34 (11): 1852–57. doi:10.1007/s00380-019-01479-x.